Xiao-fang Wang

Nanchang, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Endomorphin analogs CEMR-1 and CEMR-2 administered intravenously display potent antinociception with limited tolerance in acute, neuropathic and inflammatory pain.

Endomorphin analogs CEMR-1 and CEMR-2 administered intravenously display potent antinociception with limited tolerance in acute, neuropathic and inflammatory pain.

Journal: Neuropharmacology

Published: October 15, 2025

Novel hybrid peptide BNT12 displays potent antinociception with limited opioid-like side effects at the spinal level.

Novel hybrid peptide BNT12 displays potent antinociception with limited opioid-like side effects at the spinal level.

Journal: Neuroscience

Published: October 13, 2025

BNT12, a novel hybrid peptide of opioid and neurotensin pharmacophores, produces potent central antinociception with limited side effects.

BNT12, a novel hybrid peptide of opioid and neurotensin pharmacophores, produces potent central antinociception with limited side effects.

Journal: European journal of pharmacology

Published: January 22, 2024

Endomorphin-2 analogs with C-terminal esterification display potent antinociceptive effects in the formalin pain test in mice.

Endomorphin-2 analogs with C-terminal esterification display potent antinociceptive effects in the formalin pain test in mice.

Journal: Peptides

Published: September 09, 2023

Novel endomorphin analogues CEMR-1 and CEMR-2 produce potent and long-lasting antinociception with a favourable side effect profile at the spinal level.

Novel endomorphin analogues CEMR-1 and CEMR-2 produce potent and long-lasting antinociception with a favourable side effect profile at the spinal level.

Journal: British journal of pharmacology

Published: December 22, 2022

Novel Cyclic Endomorphin Analogues with Multiple Modifications and Oligoarginine Vector Exhibit Potent Antinociception with Reduced Opioid-like Side Effects.

Novel Cyclic Endomorphin Analogues with Multiple Modifications and Oligoarginine Vector Exhibit Potent Antinociception with Reduced Opioid-like Side Effects.

Journal: Journal of medicinal chemistry

Published: November 16, 2021

The spinal anti-allodynic effects of endomorphin analogs with C-terminal hydrazide modification in neuropathic pain model.

The spinal anti-allodynic effects of endomorphin analogs with C-terminal hydrazide modification in neuropathic pain model.

Journal: Peptides

Published: June 16, 2020

Endomorphin-1 analogs with oligoarginine-conjugation at C-terminus produce potent antinociception with reduced opioid tolerance in paw withdrawal test.

Endomorphin-1 analogs with oligoarginine-conjugation at C-terminus produce potent antinociception with reduced opioid tolerance in paw withdrawal test.

Journal: Peptides

Published: March 30, 2018

Showing 1-8 of 8

Last Updated: 09/26/2026